- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report focuses on the Alzheimer’s Disease Therapeutics and Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014.
The worldwide market for Alzheimer’s Disease Therapeutics and Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Eisai
Novartis
Forest Laboratories
TauRx Therapeutics
AC Immune
Johnson & Johnson.
H. Lundbeck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lumbar puncture test
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)
Electroencephalography (EEG)
Positron emission tomography (PET) scan
Others
Market Segment by Applications, can be divided into
Marketed Drugs
Pipeline Drugs
There are 15 Chapters to deeply display the global Alzheimer’s Disease Therapeutics and Diagnostics market.
Chapter 1, to describe Alzheimer’s Disease Therapeutics and Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer’s Disease Therapeutics and Diagnostics, with sales, revenue, and price of Alzheimer’s Disease Therapeutics and Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer’s Disease Therapeutics and Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer’s Disease Therapeutics and Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer’s Disease Therapeutics and Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alzheimer’s Disease Therapeutics and Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Lumbar puncture test
1.2.2 Computed tomography (CT) scan
1.2.3 Magnetic resonance imaging (MRI)
1.2.4 Electroencephalography (EEG)
1.2.5 Positron emission tomography (PET) scan
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Marketed Drugs
1.3.2 Pipeline Drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Forest Laboratories
2.4.1 Business Overview
2.4.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 TauRx Therapeutics
2.5.1 Business Overview
2.5.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AC Immune
2.6.1 Business Overview
2.6.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson.
2.7.1 Business Overview
2.7.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 H. Lundbeck
2.8.1 Business Overview
2.8.2 Alzheimer’s Disease Therapeutics and Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer Market Share in 2017
3.3.2 Top 6 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Analysis by Regions
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5 North America Alzheimer’s Disease Therapeutics and Diagnostics by Countries
5.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
5.1.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6 Europe Alzheimer’s Disease Therapeutics and Diagnostics by Countries
6.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics by Countries
7.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8 South America Alzheimer’s Disease Therapeutics and Diagnostics by Countries
8.1 South America Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 South America Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics by Countries
9.1 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
10 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment by Type
10.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
10.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Lumbar puncture test Sales Growth and Price
10.2.1 Global Lumbar puncture test Sales Growth (2013-2018)
10.2.2 Global Lumbar puncture test Price (2013-2018)
10.3 Computed tomography (CT) scan Sales Growth and Price
10.3.1 Global Computed tomography (CT) scan Sales Growth (2013-2018)
10.3.2 Global Computed tomography (CT) scan Price (2013-2018)
10.4 Magnetic resonance imaging (MRI) Sales Growth and Price
10.4.1 Global Magnetic resonance imaging (MRI) Sales Growth (2013-2018)
10.4.2 Global Magnetic resonance imaging (MRI) Price (2013-2018)
10.5 Electroencephalography (EEG) Sales Growth and Price
10.5.1 Global Electroencephalography (EEG) Sales Growth (2013-2018)
10.5.2 Global Electroencephalography (EEG) Price (2013-2018)
10.6 Positron emission tomography (PET) scan Sales Growth and Price
10.6.1 Global Positron emission tomography (PET) scan Sales Growth (2013-2018)
10.6.2 Global Positron emission tomography (PET) scan Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment by Application
11.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
11.2 Marketed Drugs Sales Growth (2013-2018)
11.3 Pipeline Drugs Sales Growth (2013-2018)
12 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Regions (2018-2023)
12.2.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.2.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.2.4 South America Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2023)
12.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Type (2018-2023)
12.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type (2018-2023)
12.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Application (2018-2023)
12.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Application (2018-2023)
12.4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alzheimer’s Disease Therapeutics and Diagnostics Picture
Table Product Specifications of Alzheimer’s Disease Therapeutics and Diagnostics
Figure Global Sales Mar
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
